Latest Articles
December 19, 2023
The Path to Clinical Relevance: What a Study on RAD51C Reveals about Resolving VUS
Marcy Richardson, PhD discusses variant interpretation, VUS, and recategorizing missense genes with an example from Hu et al’s recent publication on RAD51C.
Genetic Testing
Genetic Testing Accuracy
PALB2
RAD51D
Variant of Unknown Significance
VUS
December 8, 2023
A Genetic Counselor’s Experience with Proactive Reanalysis through Patient for Life: An Interview with Kelly Minks, MS, CGC
Meagan Farmer interviews Kelly Minks, MS, CGC, a genetic counselor in the Department of Neurology at the University of Rochester Medical Center, who routinely orders…
Epilepsy
Genetic Counselors
Genetic Testing
Whole Exome Sequencing
December 5, 2023
Addressing equity in exome sequencing: Proactive reanalysis through the Ambry Patient for Life program helps to reduce racial, ethnic, and ancestral disparities
Emerging evidence shows that exome sequencing outcomes can see similar racial and ethnic disparities as other genetic tests. Therefore, exome reanalysis represents a step to…
Genetic Discrimination
Hereditary Cancer
Whole Exome Sequencing
November 20, 2023
Guest Blog: The Importance of Family Health History
Genetic counselor Tawanna St. Lewis discusses the importance of family health history and genetic testing.
Family History
Genetic Testing
October 25, 2023
Off My Chest: How Negative Genetic Testing and a Supportive Community Helped Me Navigate Breast Cancer
Kristina O’Quinn shares her experience as a breast cancer survivor who underwent genetic testing to help inform her mastectomy choices.
Breast Cancer
Breast Cancer Awareness
Genetic Testing
October 18, 2023
Breast Cancer Awareness Month: CHEK2 with Petra Kleiblova and Zdenek Kleibl
Petra Kleiblova and Dr. Zdenek Kleib’s commentary on ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast…
BRCA1 & 2
Breast Cancer Awareness
CHEK2